Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $52.5 million in growth funding co-led by existing investor General Catalyst and international investment company Kinnevik. Singapore-based EDBI, American Investment Holdings LLC, and Microsoft Ventures also joined the round including participation from previous investors. The company plans to utilize the funding to expand its diabetes management to international markets
Read More
Diabetes Management Platform | Type 1 & 2 Diabetes Patients | News, Analysis, Insights - HIT Consultant
Common Sensing, Welkin Health Partner to Develop Innovative Insulin Adherence Program
Insulin adherence remains a significant challenge with approximately 62 percent of patients discontinuing insulin in the first three months and 82 percent in the first year. To resolve this challenge, Common Sensing and Welkin Health have partnered to develop an innovative new program aimed at improving insulin adherence for people living with diabetes. A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap™, real-time
Read More
Grady Health Goes Live on Glytec’s Personalized Diabetes Therapy Management Platform
Atlanta’s Grady Health System has implemented the Glytec eGlycemic Management System®, a personalized diabetes therapy management solution seamlessly integrated with the Epic EMR. Glytec's eGMS® is currently deployed across all critical care areas -- each assigned an interdisciplinary team of pharmacy, medical and nursing staff to provide localized glycemic governance.Integration with Epic EMReGMS integration with Epic's EMR will allow users direct access from a patient’s chart without the need
Read More
WellDoc Receives FDA 510(k) Clearance for Non-Prescription Version of BlueStar® Digital Therapeutic
Digital health leader WellDoc has received FDA 510(k) class II clearance for a non-prescription version of the BlueStar® digital therapeutic diabetes management platform. This news comes on the heels of two other significant recent announcements for BlueStar®: the FDA’s clearance of the wireless integration of LifeScan’s OneTouch Verio Flex® blood glucose monitoring system with BlueStar®, and plans to incorporate the American Association of Diabetes Educators’ (AADE) curriculum in the BlueStar®
Read More
FDA Clears Wireless Integration of LifeScan’s OneTouch With WellDoc’s Diabetes Management Platform
The U.S. Food and Drug Administration (FDA) announced it has cleared the wireless integration of the OneTouch Verio Flex® blood glucose monitoring system with WellDoc Inc.'s clinically validated diabetes management platform, BlueStar®. The integration will create an integrated, connected experience for people with Type 2 diabetes and deliver value for healthcare providers. Integration DetailsUsing blood glucose data wirelessly and automatically transmitted from the OneTouch Verio Flex blood
Read More
WellDoc, LifeScan Integrate to Create Type 2 Diabetes Management Platform
WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
Livongo Health Pulls In $45M to Expand Diabetes Management
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $44.5 million in Series C funding from investors including Merck Global Health Innovation Fund; Cowen Private Investments; Sapphire Ventures; Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts; Wanxiang America Corporation. Existing investors General Catalyst, Kleiner Perkins Caufield & Byers (KPCB), DFJ, and 7wire Ventures. also
Read More
Glooko Launches Office Kiosk for In-Clinic Diabetes Care
Glooko Inc., a unified platform for diabetes management, today announced the official launch of its “Glooko Office Kiosk” package to redefine in-clinic diabetes care experience for patients with diabetes and healthcare professionals by bringing insights that drive teachable moments to patient-clinician interactions For the first time, Glooko Office Kiosk enables diabetes data from popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs) to be synced to an Android
Read More
